The sales of blood and blood-forming organs medicine in the UK are experiencing a steady growth trajectory from 2023 to 2028. Forecasts indicate an increase from 2.36 billion USD in 2024 to 2.65 billion USD in 2028. Year-on-year growth rates are consistent, with minor fluctuations, showcasing a stable demand in the market. The compound annual growth rate (CAGR) over this period suggests a modest but steady increase annually.

Future trends to watch for include:

Emerging therapies and innovations in the treatment of hematological disorders and blood-related conditions.
Regulatory changes and their potential impacts on drug approvals and pricing.
Growing demand driven by an aging population and increasing prevalence of blood-related health issues.